Showing results (1601-1610 of 1,712) with videos related to

Sort By:
Pageof 172
Neurology India|November 10, 2022
A New Practical Method Based on MRI to Individually Localize the Transverse-Sigmoid Sinus Junction in Retrosigmoid Craniotomy: A Retrospective Before-After StudyTian-Zhi Zhao, Wei Shi, Lang-Lang Feng, et al.
Current Cancer Drug Targets|June 29, 2019
The Role of Shcbp1 in Signaling and DiseaseGeng-Yuan Zhang, Zhi-Jian Ma, Long Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 15, 2019
Ultrahigh Photocatalytic Rate at a Single-Metal-Atom-OxideCong Wang, Ang Li, Chong Li, et al.
Biomaterials|June 11, 2025
A soft-hard hybrid scaffold for osteochondral regeneration through integration of composite hydrogel and biodegradable magnesiumZijie Pei, Haojing Xu, Minzheng Guo, et al.
ACS Nano|October 7, 2020
Conductive Hydrogel for a Photothermal-Responsive Stretchable Artificial Nerve and Coalescing with a Damaged Peripheral NerveMei Dong, Bo Shi, Dun Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 22, 2023
Reshaping the Endogenous Electric Field to Boost Wound Repair via Electrogenerative DressingRuizeng Luo, Yi Liang, Jinrui Yang, et al.
Frontiers in Oncology|November 5, 2021
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten PatientsWenwen Zhang, Bingyang Hu, Jun Han, et al.
Oxidative Medicine and Cellular Longevity|February 23, 2023
P7C3-A20 Attenuates Microglial Inflammation and Brain Injury after ICH through Activating the NAD+/Sirt3 PathwayYang Wu, Qing Hu, Xun Wu, et al.
International Journal of Surgery (London, England)|September 7, 2023
Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trialYuan Tian, Peigang Yang, Honghai Guo, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancerGuangrui Fan, Xiongfei Luo, Kun Li, et al.
Pageof 172